CORD-19:02a37452d5c5906b46021fbfa99a96df71704b65 / 8552-8803
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T42","span":{"begin":0,"end":251},"obj":"Sentence"},{"id":"TextSentencer_T42","span":{"begin":0,"end":251},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Injection of lysolecithin creates a focal area of demyelination characterised by the presence of demyelinated axons, loss of myelin protein mRNAs and a robust macrophage response (Blakemore, 1976; Woodruff and Franklin, 1999; Ousman and David, 2000) ."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T42","span":{"begin":0,"end":251},"obj":"Sentence"}],"text":"Injection of lysolecithin creates a focal area of demyelination characterised by the presence of demyelinated axons, loss of myelin protein mRNAs and a robust macrophage response (Blakemore, 1976; Woodruff and Franklin, 1999; Ousman and David, 2000) ."}
CORD-19-PD-HP
{"project":"CORD-19-PD-HP","denotations":[{"id":"T13","span":{"begin":50,"end":63},"obj":"Phenotype"}],"attributes":[{"id":"A13","pred":"hp_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/HP_0011096"}],"text":"Injection of lysolecithin creates a focal area of demyelination characterised by the presence of demyelinated axons, loss of myelin protein mRNAs and a robust macrophage response (Blakemore, 1976; Woodruff and Franklin, 1999; Ousman and David, 2000) ."}
CORD-19-PD-UBERON
{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T14","span":{"begin":125,"end":131},"obj":"Body_part"}],"attributes":[{"id":"A14","pred":"uberon_id","subj":"T14","obj":"http://purl.obolibrary.org/obo/UBERON_0000345"}],"text":"Injection of lysolecithin creates a focal area of demyelination characterised by the presence of demyelinated axons, loss of myelin protein mRNAs and a robust macrophage response (Blakemore, 1976; Woodruff and Franklin, 1999; Ousman and David, 2000) ."}